Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
13.52
+0.29 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
13.73
+0.21 (1.56%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Zevra Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $26 | Buy | Reiterates | $26 | +92.31% | Jun 23, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $25 → $35 | Buy | Reiterates | $25 → $35 | +158.88% | Jun 10, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +114.50% | Jun 10, 2026 |
| BTIG | BTIG | Buy Reiterates $23 → $27 | Buy | Reiterates | $23 → $27 | +99.70% | Jun 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $29 | Buy | Reiterates | $29 | +114.50% | Jun 9, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $18 → $25 | Buy | Maintains | $18 → $25 | +84.91% | Jun 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $24 → $34 | Buy | Maintains | $24 → $34 | +151.48% | Jun 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.